Rexford Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Rexford Capital's NVS Position: Q1 2026 in Review
Rexford Capital increased its Novartis (NVS) stake by 0.16% in Q1 2026, buying an estimated $1.23K and bringing the position to 5,002 shares worth $764K. The position accounts for 0.55% of the portfolio, ranked #55.
Rexford Capital first reported a position in NVS in Q2 2025 and has held it in 4 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Rexford Capital held 5,002 shares of Novartis worth $764K as of Q1 2026.
- Rexford Capital bought 8 Novartis shares in Q1 2026, an estimated $1.23K.
- Novartis made up 0.55% of Rexford Capital's portfolio in Q1 2026, its #55 holding.
- Rexford Capital first reported a position in Novartis in Q2 2025 and has held it in 4 quarters since.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Rexford Capital's 13F filing for Q1 2026, filed 24 Apr 2026.